London, England, United KingdomFounded 202120+ employeesPrivate
$8.8M raisedSeed· last: seed (May 2023)· 3 rounds
Backed by(12 investors)
MultiOmic Health is building the next generation of precision therapeutics for cardiovascular-renal-metabolic (CRM) diseases by identifying and addressing the needs of specific patient subpopulations. Our approach combines AI-enabled analytics with custom-assembled, patient-derived datasets, integrating longitudinal clinical data and multi-omics. This allows us to discover patient-stratifying biomarkers and generate targeted therapeutic candidates tailored to distinct patient endotypes.
